Announcement of Exhibition at the 33rd Annual Meeting of the Japan Sjögren’s Syndrome Society (Ongoing)

The 33rd Annual Meeting of the Japan Sjögren’s Syndrome Society is being held today, September 19–20, 2025, at Congress Square Haneda.

ProteoBridge, Inc., in collaboration with FUSHIMI Pharmaceutical Co., Ltd., is exhibiting at Booth No. 3.

At our booth, we are introducing our biomarker analysis services, along with the latest technologies that support both research and clinical applications. In particular, we are showcasing initiatives based on proteomics that contribute to advancing autoimmune disease research and accelerating drug discovery.

We warmly welcome all attendees to stop by our booth.

📍 Please see here for a view of our exhibition booth

Exhibition Overview

• Exhibition Name: 33rd Annual Meeting of the Japan Sjögren’s Syndrome Society
• Dates: September 19 (Fri) – 20 (Sat), 2025
• Venue: Congress Square Haneda
  (Zone J, Haneda Innovation City, 1-1-4 Haneda Airport, Ota-ku, Tokyo)
• Booth Number: Lounge B [No. 3]
• Co-exhibitors: FUSHIMI Pharmaceutical Co., Ltd. / ProteoBridge, Inc.
• Official Website: https://www.congre.co.jp/jsss33/index.html